Development and validation of an HPLC-DAD method for the quantification of cannabigerol, cannabidiol, cannabinol and cannabichromene in human plasma and mouse matrices

This HPLC-DAD method allows a selective, accurate and precise quantification of cannabigerol, cannabidiol, cannabinol and cannabichromene. It demonstrated to be applicable to pre-clinical studies and therapeutic drug monitoring of cannabidiol.